Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

被引:52
|
作者
Basch, Ethan [1 ,3 ]
Dueck, Amylou C. [4 ]
Rogak, Lauren J. [3 ]
Mitchell, Sandra A. [5 ]
Minasian, Lori M. [5 ]
Denicoff, Andrea M. [5 ]
Wind, Jennifer K. [6 ]
Shaw, Mary C. [3 ]
Heon, Narre [3 ]
Shi, Qian [7 ]
Ginos, Brenda [4 ]
Nelson, Garth D. [7 ]
Meyers, Jeffrey P. [7 ]
Chang, George J. [8 ]
Mamon, Harvey J. [6 ]
Weiser, Martin R. [3 ]
Kolevska, Tatjana [9 ]
Reeve, Bryce B. [2 ]
Bruner, Deborah Watkins [10 ]
Schrag, Deborah [6 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, 170 Manning Dr, Chapel Hill, NC 27516 USA
[2] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Mayo Clin, Alliance Stat & Data Ctr, Scottsdale, AZ USA
[5] NCI, Rockville, MD USA
[6] Dana Farber Partners CancerCare, Boston, MA USA
[7] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Kaiser Permanente Vallejo Med Ctr, Vallejo, CA USA
[10] Emory Univ, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1200/JCO.2018.78.8620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable patient reporting of symptomatic adverse events in oncology clinical research. This study was designed to assess the feasibility and resource requirements associated with implementing PRO-CTCAE in a multicenter trial.MethodsPatients with locally advanced rectal cancer enrolled in the National Cancer Institute-sponsored North Central Cancer Treatment Group (Alliance) Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and Total Mesorectal Excision trial were asked to self-report 30 PRO-CTCAE items weekly from home during preoperative therapy, and every 6 months after surgery, via either the Web or an automated telephone system. If participants did not self-report within 3 days, a central coordinator called them to complete the items. Compliance was defined as the proportion of participants who completed PRO-CTCAE assessments at expected time points.ResultsThe prespecified PRO-CTCAE analysis was conducted after the 500th patient completed the 6-month follow-up (median age, 56 years; 33% female; 12% nonwhite; 43% high school education or less; 5% Spanish speaking), across 165 sites. PRO-CTCAE was reported by participants at 4,491 of 4,882 expected preoperative time points (92.0% compliance), of which 3,771 (77.2%) were self-reported by participants and 720 (14.7%) were collected via central coordinator backup. Compliance at 6-month post-treatment follow-up was 333 of 468 (71.2%), with 122 (26.1%) via backup. Site research associates spent a median of 15 minutes on PRO-CTCAE work for each patient visit. Work by a central coordinator required a 50% time commitment.ConclusionHome-based reporting of PRO-CTCAE in a multicenter trial is feasible, with high patient compliance and low site administrative requirements. PRO-CTCAE data capture is improved through centralized backup calls.
引用
收藏
页码:3120 / +
页数:10
相关论文
共 50 条
  • [41] Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Benjamin Arnold
    Sandra A. Mitchell
    Lauren Lent
    Tito R. Mendoza
    Lauren J. Rogak
    Natalie M. Barragán
    Gordon Willis
    Mauricio Medina
    Suzanne Lechner
    Frank J. Penedo
    Jay K. Harness
    Ethan M. Basch
    Supportive Care in Cancer, 2016, 24 : 2843 - 2851
  • [42] Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Arnold, Benjamin
    Mitchell, Sandra A.
    Lent, Lauren
    Mendoza, Tito R.
    Rogak, Lauren J.
    Barragan, Natalie M.
    Willis, Gordon
    Medina, Mauricio
    Lechner, Suzanne
    Penedo, Frank J.
    Harness, Jay K.
    Basch, Ethan M.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (07) : 2843 - 2851
  • [43] Sensitivity of Study Results to Patient-Reported Data Collected Through Backup Phone Calls (NCCTG N1048 [Alliance])
    Mazza, Gina L.
    Basch, Ethan
    Ginos, Brenda
    Rogak, Lauren
    Shi, Qian
    Mitchell, Sandra A.
    Minasian, Lori
    Denicoff, Andrea
    Thanarajasingam, Gita
    Schrag, Deborah
    Dueck, Amylou C.
    QUALITY OF LIFE RESEARCH, 2024, 33 : S142 - S143
  • [44] Validation of the German Patient- Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
    Hagelstein, V.
    Ortland, I.
    Wilmer, A.
    Mitchell, S. A.
    Jaehde, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 6 - +
  • [45] Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Lee, Minji K.
    Schalet, Benjamin D.
    Cella, David
    Yost, Kathleen J.
    Dueck, Amylou C.
    Novotny, Paul J.
    Sloan, Jeff A.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)
  • [46] Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Minji K. Lee
    Benjamin D. Schalet
    David Cella
    Kathleen J. Yost
    Amylou C. Dueck
    Paul J. Novotny
    Jeff A. Sloan
    Journal of Patient-Reported Outcomes, 4
  • [47] Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
    Basch, Ethan
    Dueck, Amylou C.
    Mitchell, Sandra A.
    Mamon, Harvey
    Weiser, Martin
    Saltz, Leonard
    Gollub, Marc
    Rogak, Lauren
    Ginos, Brenda
    Mazza, Gina L.
    Colgrove, Brian
    Chang, George
    Minasian, Lori
    Denicoff, Andrea
    Thanarajasingam, Gita
    Musher, Benjamin
    George, Thomas
    Venook, Alan
    Farma, Jeffrey
    O'Reilly, Eileen
    Meyerhardt, Jeffrey A.
    Shi, Qian
    Schrag, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (21) : 3724 - +
  • [48] Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
    Basch, E.
    Dueck, A. C.
    Mitchell, S. A.
    DISEASES OF THE COLON & RECTUM, 2023, 66 (10) : 1403 - 1403
  • [49] Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Minji K. Lee
    Benjamin D. Schalet
    David Cella
    Kathleen J. Yost
    Amylou C. Dueck
    Paul J. Novotny
    Jeff A. Sloan
    Journal of Patient-Reported Outcomes, 5
  • [50] Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Jennifer L. Hay
    Thomas M. Atkinson
    Bryce B. Reeve
    Sandra A. Mitchell
    Tito R. Mendoza
    Gordon Willis
    Lori M. Minasian
    Steven B. Clauser
    Andrea Denicoff
    Ann O’Mara
    Alice Chen
    Antonia V. Bennett
    Diane B. Paul
    Joshua Gagne
    Lauren Rogak
    Laura Sit
    Vish Viswanath
    Deborah Schrag
    Ethan Basch
    Quality of Life Research, 2014, 23 : 257 - 269